Cost of Cancer Diagnostic & Staging Package in Saudi Arabia
A transparent financial outline allows patients and families to plan their diagnostic trip with clarity. The all-inclusive package for full oncological workup and staging in Riyadh is set at USD 13,000. This bundle consolidates specialist consultations, laboratory panels, cross-sectional imaging, tissue sampling, and tumor board reviews into a coordinated schedule. Below is a comparative overview of standard complex diagnostic workups across international medical centers.
| Location / Diagnostic Center | Price in USD | Comparative Value Note |
|---|---|---|
| Saudi Arabia (KFSHRC) | $13,000 USD | All-inclusive clustered diagnostic & staging rate |
| United States | $28,000 – $45,000 USD | Unbundled facility fees, separate radiologist & pathology billing |
| United Kingdom | $22,000 – $35,000 USD | Private center pricing for combined PET-CT, biopsy, and IHC panels |
| Western Europe | $20,000 – $32,000 USD | A-la-carte diagnostic, biopsy, and specialist consultation rates |
Note: Proposed pricing is fixed for standard diagnostic and staging protocols. Final clinical expenses may vary if non-standard specialized interventions or secondary tissue sampling procedures are requested.
What Is Covered in Your Cancer Diagnostic Package?
Your diagnostic pathway is designed to gather complete pathological and metabolic data efficiently over a 2 to 4-day period. The USD 13,000 package includes the following clinical services:
-
Initial medical evaluation by an attending medical oncologist or organ-specific specialist.
-
Baseline bloodwork panel including complete blood count, organ function tests, and routine tumor markers.
-
Core cross-sectional anatomical imaging, including contrast-enhanced CT and/or MRI scans via Oncology Diagnostic Imaging in Saudi Arabia.
-
Tissue sampling via core needle biopsy or image-guided intervention using a Cancer Biopsy in Saudi Arabia protocol.
-
Histopathological evaluation accompanied by standard immunohistochemistry (IHC) profiling.
-
Whole-body PET-CT scan or equivalent metabolic staging imaging when clinically indicated.
-
Multidisciplinary Team (MDT) / Tumor Board case review for consensus treatment planning.
-
Formal written cancer staging report and comprehensive treatment recommendation document.
-
In-person or structured exit consultation for diagnostic results review and next-step counselling.
What Is Excluded from the Package Offer?
To maintain clear financial boundaries, procedures outside the initial diagnostic and staging scope are excluded from the baseline package:
-
Definitive cancer treatments (including surgical resection, chemotherapy, radiotherapy, immunotherapy, or targeted therapy).
-
Major inpatient surgical interventions unrelated to obtaining a diagnostic tissue sample.
-
Highly specialized molecular profiling, comprehensive genomic profiling (CGP), or large Next-Generation Sequencing (NGS) panels.
-
Repeat biopsy procedures resulting from non-diagnostic sampling or inadequate tissue yield outside standard protocol.
-
Management of acute medical complications, emergency stabilization, or Intensive Care Unit (ICU) admissions.
-
Prolonged inpatient hospital stays exceeding the standard outpatient diagnostic pathway.
-
Long-term follow-up consultations, post-diagnostic monitoring, or oncological rehabilitation services.
-
Advanced hereditary genetic testing panels and non-routine biomarker packages.
-
Additional specialist consultations unrelated to the primary oncological diagnosis.
Understanding the Cancer Diagnosis & Full Staging Pathway
Accurate cancer staging requires a coordinated two-part clinical assessment: confirming the precise microscopic cellular type (histopathology) and measuring the physical reach of the primary tumor throughout the body (radiological staging). Without a complete diagnostic baseline, choosing treatment modalities—such as surgery, radiation, or systemic therapy—carries clinical uncertainty.
During this short diagnostic stay in Riyadh, image-guided biopsy techniques ensure precise, minimally invasive sampling of suspicious lesions. Advanced imaging technologies, including high-field MRI, multi-slice contrast CT, and metabolic PET-CT, operate in tandem to detect localized spread, lymph node involvement, or distant metastasis. The collected findings are synthesized during an expert multidisciplinary tumor board meeting, providing a clear roadmap for subsequent therapeutic decisions.
Why Choose King Faisal Specialist Hospital & Research Centre?
Selecting an established institution for complex cancer diagnostics gives patients access to specialized medical equipment and experienced clinical subspecialists:
-
Subspecialized Pathology Expertise: Dedicated anatomical pathologists skilled in complex immunohistochemistry and organ-specific tumor classification.
-
Advanced Diagnostic Infrastructure: Fully integrated PET-CT suites, high-resolution MRI, and dedicated interventional radiology suites for image-guided biopsies.
-
Multidisciplinary Tumor Boards: Regular case reviews bringing together surgical oncologists, medical oncologists, radiation oncologists, radiodiagnosticians, and pathologists.
-
Clustered Outpatient Pathway: A streamlined diagnostic schedule engineered to complete imaging, biopsy, and pathology analysis within 2 to 4 days.
-
International Administrative Coordination: Established protocols for serving regional and international patients seeking definitive diagnostic clarity.
Your Diagnostic Journey: Sample Hospital Timeline
The clinical schedule for your staging workup is organized across a 2 to 4-day clustered outpatient stay to maximize efficiency and minimize delay:
-
Day 1: Clinical Intake & Initial Investigations
-
Arrival and consultation with the attending oncologist or organ specialist.
-
Execution of baseline blood tests, metabolic panels, and routine tumor marker assays.
-
Core cross-sectional anatomical imaging (contrast CT and/or MRI scans).
-
-
Day 2: Tissue Sampling & Metabolic Staging
-
Performance of image-guided core biopsy or endoscopic tissue sampling under local anesthesia or light sedation.
-
Whole-body PET-CT scanning for metabolic staging when clinically required.
-
Tissue sample transfer to the pathology laboratory for histological and IHC processing.
-
-
Days 3–4: MDT Review & Counseling
-
Multidisciplinary Tumor Board discussion to integrate pathology results with imaging stages.
-
Formulation of the written staging summary and treatment planning document.
-
Final exit consultation for in-depth results review, counselling, and care coordination guidance.
-
Expected Results from the Diagnostic & Staging Package
Completing this structured diagnostic pathway provides patients with a validated diagnosis, establishing the exact histological tumor type, grade, and staging classification (TNM parameters). Equipped with an expert multidisciplinary tumor board summary, patients obtain a clear foundation to discuss definitive treatment options—whether surgical, systemic, or radiotherapeutic—with their primary treating oncologists at home or abroad.
Advantages of Receiving Oncology Care in Saudi Arabia
-
Tertiary Healthcare Standards: Diagnostic evaluations conducted within advanced facilities like King Faisal Specialist Hospital and Research Centre.
-
Integrated Subspecialties: Radiologists, pathologists, and clinical oncologists working under unified care protocols.
-
Rapid Diagnostic Turnaround: Clustered scheduling reduces waiting periods between tissue collection, imaging, and tumor board review.
-
Regional Connectivity: Modern transport links and health infrastructure facilitate medical visits to Riyadh for international travelers.
Frequently Asked Questions
1. What is included in the Cancer Diagnosis & Full Staging Package?
The USD 13,000 package includes initial specialist consultations, baseline bloodwork, routine tumor markers, contrast CT/MRI, core tissue biopsy, histopathology with standard IHC, PET-CT staging imaging, multidisciplinary tumor board review, and a written staging summary.
2. How long does the diagnostic stay take in Riyadh?
The clustered diagnostic pathway is completed within 2 to 4 days on an outpatient basis, depending on tissue processing times and imaging schedules.
3. Is definitive cancer treatment included in this package?
No. This package focuses exclusively on diagnosis and staging. Treatment modalities such as chemotherapy, surgery, or radiation therapy are excluded and planned separately.
4. What type of biopsy is performed under this program?
The package covers standard core needle biopsies or image-guided biopsies suitable for acquiring tissue samples for histopathology and immunohistochemistry.
5. Are advanced Next-Generation Sequencing (NGS) panels covered?
No. Standard immunohistochemistry is included, but non-routine biomarker panels, large genomic sequencing, and advanced genetic profiling are excluded.
6. What role does the Multidisciplinary Tumor Board play?
The tumor board brings together specialists from oncology, pathology, and radiology to review all diagnostic data collaboratively, reaching a consensus staging assessment.
7. Is an inpatient admission required for these diagnostic tests?
No. The program operates as a clustered outpatient pathway, allowing patients to stay in nearby accommodation between scheduled hospital appointments.
8. Does the package cover treatment for complications or ICU stay?
No. Management of acute medical complications, emergency hospitalizations, and ICU admissions fall outside the baseline diagnostic bundle.
9. Will I receive a formal written summary of my staging results?
Yes. Every patient receives a comprehensive written staging document and multidisciplinary recommendation report upon completion of the evaluation.
10. How can international patients arrange a diagnostic trip to Riyadh?
Patients can submit existing medical records and imaging through PlacidWay to coordinate consultation schedules and diagnostic appointments prior to arrival.
Take the Next Step in Your Diagnostic Journey
Gaining precise diagnostic clarity is essential for planning effective oncological care. Through PlacidWay, you can connect with King Faisal Specialist Hospital & Research Centre to schedule your Oncology Diagnostic Imaging in Saudi Arabia and comprehensive staging pathway.
-
Direct communication and coordination with the international patient care team in Riyadh.
-
Clear, itemized diagnostic package guidelines covering consultations, imaging, biopsy, and staging reports.
-
Secure submission of prior medical records and preliminary scans for care scheduling.
-
Dedicated assistance for administrative planning throughout your diagnostic visit.
Request your detailed medical quote today to begin your diagnostic coordination.
Get a Free Quote
-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
-Prostate-Cancer-Treatment-in-Saudi-Arabia-Thumbnail.jpg)
Share this listing